Takeda Pharmaceutical Co. Ltd. ADR (TAK) Social Stream
TAKEDA PHARMACEUTICAL CO LTD (TAK) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering TAKEDA PHARMACEUTICAL CO LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-06 | 3 | $21 | $17.6 | $18.866 | $14.72 | 28.17% |
| 2021-12-08 | 3 | $21 | $15 | $17.867 | $14.72 | 21.38% |
| 2022-01-16 | 3 | $21 | $15 | $17.866 | $14.72 | 21.37% |
| 2022-02-23 | 3 | $21 | $15 | $17.466 | $14.72 | 18.65% |
| 2022-05-12 | 3 | $21 | $16.4 | $17.933 | $14.72 | 21.83% |
| 2022-05-30 | 3 | $21 | $16.4 | $18.166 | $14.72 | 23.41% |
| 2022-07-29 | 3 | $24 | $13.8 | $18.3 | $14.72 | 24.32% |
| 2022-08-14 | 3 | $24 | $13.8 | $18.1 | $14.72 | 22.96% |
| 2022-09-17 | 3 | $24 | $13.8 | $18 | $14.72 | 22.28% |
| 2022-10-28 | 3 | $24 | $12.8 | $17.666 | $14.72 | 20.01% |
| 2022-12-15 | 3 | $24 | $12.8 | $17.4 | $14.72 | 18.21% |
| 2023-01-27 | 3 | $24 | $12.8 | $17.766 | $14.72 | 20.69% |
| 2023-02-21 | 2 | $24 | $12.8 | $18.033 | $14.72 | 22.51% |
| 2023-03-10 | 3 | $24 | $14.4 | $18.566 | $14.72 | 26.13% |
| 2023-03-17 | 3 | $24 | $14.4 | $19.466 | $14.72 | 32.24% |
| 2023-05-15 | 3 | $30 | $14.4 | $21.466 | $14.72 | 45.83% |
| 2023-05-24 | 3 | $20 | $14.4 | $18.133 | $14.72 | 23.19% |
| 2023-06-12 | 3 | $20 | $14.4 | $17.466 | $14.72 | 18.65% |
| 2023-08-28 | 3 | $20 | $14.2 | $17.4 | $14.72 | 18.21% |
| 2023-09-06 | 3 | $20 | $14 | $17.333 | $14.72 | 17.75% |
| 2023-10-26 | 3 | $20 | $14 | $17 | $14.72 | 15.49% |
| 2023-11-27 | 3 | $20 | $13.7 | $16.9 | $14.72 | 14.81% |
| 2023-12-08 | 3 | $20 | $13.7 | $16.966 | $14.72 | 15.26% |
The Trend in the Analyst Price Target
Over the past 19 months, TAK's average price target has gone down $0.97.
TAK reports an average of 17.37% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 3 | 24 | 12.8 | 17.766 | 16.03 | 10.83% |
| 2023-02-21 | 3 | 24 | 12.8 | 18.033 | 15.89 | 13.49% |
| 2023-03-17 | 3 | 24 | 14.4 | 19.466 | 16.39 | 18.77% |
| 2023-06-12 | 3 | 20 | 14.4 | 17.466 | 16.07 | 8.69% |
| 2023-10-26 | 3 | 20 | 14.0 | 17.000 | 13.38 | 27.06% |
TAK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 2 | 0 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
TAK's average broker recommendation rating improved by 1.33 over the prior 26 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TAK as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, TAKEDA PHARMACEUTICAL CO LTD's number of analysts covering the stock is higher than 187.33% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, TAKEDA PHARMACEUTICAL CO LTD's average analyst price target is higher than 242.22% of them.
- In terms of how TAKEDA PHARMACEUTICAL CO LTD fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 608.51% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, TAKEDA PHARMACEUTICAL CO LTD's variance in analysts' estimates is lower than -617.78% of them.
Stocks similar to TAKEDA PHARMACEUTICAL CO LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GSK, SNY, and VTRS.
View All Top Stocks by Price Target
Make investment decisions regarding TAK using the data that counts. Try POWR Ratings for free.